Related Experiment Video
Updated: Jan 17, 2026

07:46
CRISPR/Cas9 Editing of the C. elegans rbm-3.2 Gene using the dpy-10 Co-CRISPR Screening Marker and Assembled Ribonucleoprotein Complexes.
Published on: December 11, 2020
6.4K
Genome-Wide CRISPR/Cas9 Screening Identifies the COMMANDER Recycling Complex as a Key Player in EV Uptake
Miguel Palma-Cobo1, Victor Toribio1, Joaquín Morales1
1Centro de Biología Molecular Severo Ochoa, IIS-IP, Universidad Autónoma de Madrid, IUBM, Madrid, Spain.
Journal of Extracellular Vesicles
|September 23, 2025
Summary
Researchers identified key genes regulating extracellular vesicle (EV) uptake using a genome-wide CRISPR screen. The COMMANDER complex was found to be crucial for EV internalization and cargo fate in target cells.
Area of Science:
- Cell Biology
- Molecular Biology
- Biotechnology
Background:
- Extracellular vesicles (EVs) are promising for therapeutic delivery.
- Understanding EV uptake mechanisms is crucial for optimizing their therapeutic potential.
Purpose of the Study:
- To identify key molecular regulators of EV internalization.
- To pinpoint candidate genes influencing EV uptake by target cells.
Main Methods:
- Genome-wide CRISPR (GWC) screen in K562 cells.
- Labeling and incubation of EVs with target cells, followed by fluorescence-activated cell sorting (FACS).
- Next-generation sequencing (NGS) to quantify sgRNA enrichment and identify significant genes.
Main Results:
- Several members of the COMMANDER complex were identified as significant hits in the GWC screen.
- Validation in knockout cell lines confirmed the role of the COMMANDER complex in EV uptake.
- Kinetic analysis indicated the COMMANDER complex influences early EV uptake and cargo fate.
Conclusions:
- The COMMANDER complex is a pivotal regulator of extracellular vesicle uptake.
- This finding advances the understanding of EV-mediated delivery mechanisms.
- Potential implications for developing targeted EV-based therapies.
Related Concept Videos
CRISPR/Cas9 Genome Editing
1.7K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
CRISPR
57.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.5K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Homologous Recombination
62.7K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.7K

